JOIN WITH US IN SUPPORTING NIH STAFF
The Bethesda Declaration: A Call for NIH and HHS Leadership to Deliver on Promises of Academic Freedom and Scientific Excellence
Dear Dr. Bhattacharya,
For staff across the National Institutes of Health (NIH), we dissent to Administration policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe. Keeping NIH at the forefront of biomedical research requires our stalwart commitment to continuous improvement. But the life-and-death nature of our work demands that changes be thoughtful and vetted. We are compelled to speak up when our leadership prioritizes political momentum over human safety and faithful stewardship of public resources.
Many have raised these concerns to NIH leadership, yet we remain pressured to implement harmful measures. Today, we come directly to you. We include Secretary Kennedy and members of Congress who oversee NIH. We look forward to working with you and Department of Health and Human Services (HHS) leadership to maintain NIH as the world leader of biomedical research.
Our Shared Commitment to Academic Freedom
Academic freedom is a core scientific principle, and we deeply appreciate your public commitment to it at your confirmation hearing, in your April 24 statement on academic freedom, and in recent media interviews. You said: "I will establish a culture of respect for free speech in science and scientific dissent at the NIH," "Dissent is the very essence of science," and "...dissenting voices need to be heard and allowed." We hope you will welcome this dissent, which we modeled after your Great Barrington Declaration.
Our Concerns
This Administration has forced NIH, under your watch, to:
1) Politicize research by halting high-quality, peer reviewed grants and contracts. Academic freedom should not be applied selectively based on political ideology. To achieve political aims, NIH has targeted multiple universities with indiscriminate grant terminations, payment freezes for ongoing research, and blanket holds on awards regardless of the quality, progress, or impact of the science. Based on political preferences and without input from NIH scientific staff or Congress, NIH is censoring critical research and programs addressing:
Health disparities. U.S. Law (42 U.S.C. § 282) states that NIH shall "utilize diverse study populations, with special consideration to biological, social, and other determinants of health that contribute to health disparities." Yet, NIH has stigmatized and abruptly cut off funding for research mislabeled "Diversity Equity and Inclusion (DEI)." Achieving your stated goal to "solve the American chronic disease crisis” requires research addressing the social and structural drivers of health disparities.
COVID-19, long COVID, and immunization. We still have much to learn about the health and social consequences of COVID-19 and our response. Such research is needed to reduce the risk of future pandemics, optimize pandemic response policies, and address the well-documented and debilitating consequences of long COVID.
Health impacts of climate change. Substantial evidence shows human-driven climate change leads to higher rates of disease and death, such as asthma, heart disease, and stillbirths. Research is critical to find effective ways to reduce these and other health impacts of climate change.
Gender identity, sexual health, and the needs of intersex people in the U.S. These topics deserve research attention, and NIH has a long tradition of supporting rigorous research in these fields.
Broad participation in biomedical research. Robust research shows diverse teams outperform homogeneous ones. A broad workforce strengthens research capacity and supports globally competitive science. Due to misunderstanding of its workforce diversity programs, NIH terminated top-scoring grants to scientists from underrepresented backgrounds, while maintaining poorer-scoring grants from standard pathways, contrary to the merit-based system that makes NIH a global research leader.
Since January 20, 2025, NIH has terminated 2,100 research grants totaling around $9.5 billion and $2.6 billion in contracts. This undercuts long-standing NIH policies designed to maximize return on investment by working with grantees to address concerns and complete studies. Many terminations contradict federal regulations that mandate protections for research participants and require grant awards to specify potential termination reasons. These terminations:
Throw away years of hard work and millions of dollars. Ending a $5 million research study when it is 80% complete does not save $1 million, it wastes $4 million.
Shirk commitments to participants, who braved personal risk to give the incredible gift of biological samples, understanding that their generosity would fuel scientific discovery and improve health.
Risk participant health. NIH trials are being halted without regard to participant safety, abruptly stopping medications or leaving participants with unmonitored device implants.
Damage hard-earned public trust, counter to your stated goal to improve trust in NIH.
We urge you as NIH Director to restore grants delayed or terminated for political reasons so that life-saving science can continue.
2) Interrupt global collaboration. We would gladly work with you to improve existing systems to monitor awards with foreign components. But dissolving foreign collaborations while we await new procedures harms research participants and slows scientific discovery, cutting American scientists off from the global scientific community, preventing access to technologies only available abroad, and eliminating critical research that crosses political borders. We urge you as NIH Director to allow rigorously peer-reviewed research with vetted foreign collaborators to continue without disruption.
3) Undermine peer review. Independent peer review is the bedrock of NIH science, directing scarce resources toward the most impactful research and ensuring credible findings that can lead to better health. Without independent peer review, we risk losing scientific integrity and public trust. NIH is ignoring peer review to cater to political whims, pulling applications prior to review and removing high-scoring grants from funding consideration. HHS has redirected this funding to unvetted projects, like the Taubenberger-Memoli vaccine project. We urge you as NIH Director to restore peer review and hold political appointees to the same standards as other scientists.
4) Enact a blanket 15% cap on indirect costs. Until recently, indirect costs were negotiated using well-established criteria, accounting for critical research needs and very real costs, such as buildings, animal facilities, computers, libraries, and administrative support. The arbitrary 15% cap would hinder research, risk viability of universities and hospitals in states across the country, force universities to rescind graduate student positions, limit undergraduate research training, and damage the incredibly successful NIH-university partnerships that have improved health through scientific advances. We urge you as NIH Director to continue indirect rates that account for the research costs borne by academic institutions.
5) Fire essential NIH staff. The cuts to talented, hardworking professionals and critical departments without thought to their purpose or need has slowed the pace of science, held up extramural grant and contract funding, made NIH less transparent and efficient, and put Clinical Center patients at risk. We urge you as NIH Director to reinstate the people who make NIH work.
Delivering on your duty to obligate NIH funds
Combined, these actions have resulted in an unprecedented reduction in NIH spending that does not reflect efficiency but rather a dramatic reduction in life-saving research. Some may use the false impression that NIH funding is not needed to justify the draconian cuts proposed in the President's Budget. This spending slowdown reflects a failure of your legal duty to use congressionally-appropriated funds for critical NIH research. Each day that NIH continues to disrupt research, your ability to deliver on this duty narrows.
Who We Are
We are workers from every Institute and Center at NIH. We are devoted to the NIH mission: to seek and apply fundamental knowledge "to enhance health, lengthen life, and reduce illness and disability." We share your stated goal of supporting impactful research that, as you said at your confirmation hearing, is "vital to our country's future and, indeed, the world's." We work hard every day to carefully steward public funds to drive impactful, cutting-edge research. We want to work together to maintain NIH's tradition of excellence.
On June 9, 2025, we sign this declaration in Bethesda, Maryland, U.S. In addition to the named signers, we include anonymous signers and speak for countless others at NIH who share our concerns but who — due to a culture of fear and suppression created by this Administration — chose not to sign their names for fear of retaliation.
Kathryn Adams
Deputy Director of the Office of Clinical
Research
NICHD
Rachel Bainbridge
IRTA Postdoctoral Fellow
NIEHS
Rakshita Balaji
NCCIH
James Baldassano, Ph.D.
NIDCD
Christina Barnett
OD
Matthew Brown
Postdoctoral Fellow
NICHD
Kelly Chen (they/them)
Postbaccalaureate Research Fellow
NHGRI
Sylvia Chou
Program Officer
NCI
EB Dickinson
Postbaccalaureate Fellow
NLM
Matthew Diller
Postdoctoral Fellow
NLM
Lee Eiden
Principal Investigator
NIMH
Peter Eriksson
Staff Scientist
NICHD
E King
NIH
Benjamin Feldman
Staff Scientist
NICHD
Melani LeDu
Grants Management Analyst
NICHD
Gerald (Jerry) Marti
Special Volunteer
NHLBI
Anuja Matthew
Scientific Review Officer
NIAID
Jennifer Meyers
Scientific Review Officer
NIAID
Keith A. Mintzer, Ph.D.
Program Officer
NHLBI
Douglas Monroe
Fellow
NCI
Ian Morgan
Postdoctoral Fellow
NIGMS/NHLBI
Alexander Myers
Postbaccalaureate Research Fellow
NIDA
Brad Newsome
Program Officer
FIC
Jenna Norton
Program Officer
NIDDK
Leah Pappalardo
Graduate Student
NICHD
Vani Pariyadath
Chief, Behavioral and Cognitive
Neuroscience Branch
Division of Neuroscience and Behavior
NIDA
Sarah Morris
Program Officer and Branch Chief
NIMH
Katrina J. Serrano
Program Officer
NIDDK
Nina Silverberg
Program Officer
NIA
Janine Simmons
Deputy Director
DPCPSI/OBSSR
Marie Stoltzfus
Postdoctoral Fellow
NICHD
Asha Storm
Program Analyst
NIBIB
Candace Tingen
Branch Chief
NICHD
Rebecca Troisi
Senior Associate Scientist
NCI
Sarah Vidal
Program Officer
NIDA
Audrey Wellons, NCI
Carmen Williams, Senior Investigator, NIEHS
Saul Malozowski
Mollie Manier
Scientific Review Officer
CSR
Matthew Manion
Postdoctoral Fellow
NICHD
Luis Alvarado, PhD
Former HPS
NINDS
Probationary termination
Jourdan Ewoldt
Former
NCI
Probationary termination
Courtney Gallen
Former Program Officer
NICHD
Probationary termination
Jalina Graham
Former Health Program Specialist
NINDS
Probationary termination
Madison Haise
Former PMF Health Specialist
OD
Probationary termination
Cynthia Hurlbert
Administrative Assistant
NIAID
Subject to reductions in force
Erin Lavik
Former CTO and Deputy, Division of Cancer
Prevention, NCI
Probationary termination
JoBeth McCarthy
Former Social and Behavioral Health Science
Administrator
NCI CRCHD
Probationary termination
Dr. Robles
Former Program Officer
NIMH
Probationary termination
Catherine Timura, PhD
Senior Health Science Policy Analyst
NINR
Subject to reductions in force
Elizabeth Tuck
NHGRI
Subject to reductions in force
MSI
Health Former Program Specialist
NIA
Probationary termination
K.M.
Health Comms Specialist
NCI/OCPL
Subject to reductions in force
RMM,
Former Public Affairs Specialist
NIDDK
Probationary termination
C.R.
Former Program Analyst
NIH
Probationary termination
MR
Former Program Specialist
NEI
Probationary termination
R
Program Director
NCI
Subject to reductions in force
JMS
Former NIH
Probationary termination
Nicole S
Former HPS
NIH
Probationary termination
A. Doe
Program Officer
NCI
Anonymous
NIH
Anonymous
NIH
Anonymous
Fellow
NIH
Anonymous
NCATS
Anonymous
NCATS
Anonymous
NCCIH
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH OD
Anonymous
NIH OD
Anonymous
NIH OD
Anonymous
NIH OD
Anonymous
NIH OD
Anonymous
Program Director
NCI
Anonymous
Program Director
NCI
Anonymous
Program Director
NCI
Anonymous
Program Director
NIDDK
Anonymous
Program Officer
NCI
Anonymous
Program Officer
NHLBI
Anonymous
Program Officer
NIA
Anonymous
Program Officer
NIAID
Anonymous
Program Officer
NIAMS
Anonymous
Program Officer
NIDA
Anonymous
Program Officer
NIDA
Anonymous
Program Officer
NIDDK
Anonymous
Program Officer
NIDDK
Anonymous
Scientific Review Officer
CSR
Anonymous
Staff Scientist
NIAID
Anonymous
Staff Scientist
NIEHS
Chimbwido
NIH
Concerned Scientist
NIDDK
E
NIMH
Empowered
NIH
Jane Doe, PhD
Program Officer
NINDS
Jane Doe
Program Officer
NIH
Jane Doe
Program Specialist
NIH
Jane Doe
Scientist
NCI
Jane Snow
Epidemiologist
NCI
Juana Doe
NCI
Subject to reductions in force
Anonymous
NIH
Subject to reductions in force
Anonymous
NIH
Subject to reductions in force
Anonymous staffer
NIH
Subject to reductions in force
Anonymous
Administrative staff
NIMH
Subject to reductions in force
Anonymous
Budget Analyst
NIH
Subject to reductions in force
Anonymous
FIC
Subject to reductions in force
Anonymous
Former NICHD
Probationary termination
Anonymous
Former NIH
Probationary termination
Anonymous
Former NIH OD
Probationary termination
Anonymous
Former NINDS
Probationary termination
Anonymous
Former Presidential Management Fellow
NIH
Probationary termination
Anonymous
Former Program Manager
NIH
Probationary termination
Anonymous
NIAAA
Subject to reductions in force
Anonymous
NIAID
Probationary termination
Anonymous
NIAMS
Subject to reductions in force
Anonymous
NIAMS
Subject to reductions in force
Anonymous
NIH
Subject to reductions in force
Anonymous
NIH
Subject to reductions in force
Anonymous
NIH
Subject to reductions in force
Anonymous
NIMH
Subject to reduction in force
Anonymous
Workforce Analyst
NCI
Subject to reductions in force
Former Division Director
NIH
Subject to reductions in force
Anonymus
Health Specialist/Program Official
Subject to reductions in force
Tara Fischer
Research Fellow
NINDS
Nina Friedman (she/her)
Predoctoral Fellow
NIMH
Anne Gershenson
Program Officer
NIGMS
Alexander Grinberg
Core Director
NICHD
Paul Grothaus, PhD
Program Officer
NIA
Katie Hajdarovic
Postdoctoral Fellow
NIDDK
Shilpa Hattangadi, MD
Program Officer
NIDDK
Jenni Pacheco
Program Officer
NIMH
Sammy Katta
NIH
Theresa Kim
Program Officer
NIA
Sarah Kobrin
Branch Chief
NCI
Konrad Krzewski
Scientific Review Officer
NIAID
Rosa Lafer-Sousa
Special Volunteer
NIMH
Alexander Jordan Lara
Postbaccalaureate Fellow
NIDCR
Rui C. Pereira de Sá
Program Director
NIBIB
Shiv Prasad
Scientific Review Officer
NIAID
Cara Pugliese
Program Officer
NIMH
Lindsey Pujanandez
Scientific Review Officer
NIAID
Carolyn Reyes-Guzman
Program Officer
NCI
Marc Rigas
Program Officer
NIGMS
Arin Rinvelt
Postbaccalaureate Fellow
NICHD
John Ritchie
Visiting Fellow
NIMH
Amilcar Rodriguez
Predoctoral Fellow
SAA NIH Fellows United
Alexa Romberg
Program Officer
NIDA
Gina Roussos
NIH
Ann-Marie Roy
Acting Branch Chief
NIAID
Marcel Salive
Program Officer
NIA
Caitlyn Barnes
Peer Review Specialist
NIAID
Subject to reductions in force
M Boyle
Former NIH
Probationary termination
Cara Anjos Breeden
NIAAA
Subject to reductions in force
Bushraa Khatib
Former Science Writer/Editor
NIDCR
Probationary termination
R.Carter,
Former Management Analyst
NIAAA
Probationary termination
Ana Choban
Former NHLBI
Probationary termination
Anna Culbertson
Former Scientific Program Specialist
NIAID
Probationary termination
Kayla Davis
Resigned Senior Health Science Policy
Analyst,
DPCPSI, OD
Subject to reductions in force
D. DiSabato
Former NINDS
Probationary termination
Yasaman Etemadi
Former Administrative Assistant
CSR
Terminated contractor
Hannah Evans
Research Associate
NEI
Subject to reductions in force
Laura Machlin
Former Program Officer
NICHD
Probationary termination
KL
NIDA
JL
NIH
MN
Postdoctoral Fellow
NICHD
HAP
NIH
MF
Program Officer
NIMH
MR
Scientific Review Officer
CSR
N.S.
NCI
Maya S
NCI
SM
Staff Clinician
NIH
Maura C.
NCI
Subject to reductions in force
FMX
NIH
Subject to reductions in force
Emma
NIH
Probationary termination
AG
NIEHS
Subject to reductions in force
Anonymous
NCI
Anonymous
NIH
Anonymous
NIH
Anonymous
PI
NIH
Anonymous
Program Official
NIH
Anonymous Scientist
NIH
Anonymous
Branch Chief
NCI
Anonymous
Branch/Division Chief
NIH
Anonymous
Center for Scientific Review
Anonymous
Deputy Division Director
NIH
Anonymous
Fellow
NCI
Anonymous
Fellow
NIMH
Anonymous
Concerned Employee
NIH
Anonymous
Grants Management Specialist
NIH
Anonymous
Health Science Administrator
DPCPSI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NCI
Anonymous
NEI
Anonymous
NIAID
Anonymous
NIAID
Anonymous
NIBIB
Anonymous
NICHD
Anonymous
NIDA
Anonymous
NIDA
Anonymous
NIDDK
Anonymous
NIDDK
Anonymous
NIDDK
Subject to reductions in force
Anonymous
NIGMS
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
NIH
Anonymous
Concerned mother and American citizen
NIH
Anonymous
NIAID
Anonymous
NIMH
Anonymous
NIMH
Anonymous
NINDS
Anonymous
NINDS
Anonymous
NINR
Anonymous
OD
Anonymous
OD
Anonymous
Office of AIDS Research
Anonymous
Office of Communication
NICHD
Subject to reductions in force
Anonymous
OD
Anonymous
PI
NIH
Anonymous
Program Director
NCI
Anonymous
Program Director
NCI
Anonymous
Program Director
NCI
Anonymous
Program Officer
NIDDK
Anonymous
Program Officer
NIH
Anonymous
Program Officer
NIH
Anonymous
Program Officer
NIH
Anonymous
Program Officer
NIH
Anonymous
Program Officer
NIH
Anonymous
Program Officer
NIH
Anonymous
Program Officer
NIH
Anonymous
Program Officer
NIH
Anonymous
Program Officer
NIMH
Anonymous
Program Officer
NIMH
Anonymous
Scientific Review Officer
CSR
Anonymous
Scientific Review Officer
NIH
Anonymous
Scientist
NIMH
Liberte Toussaint Louverture
Anonymous
NIH
MC
Clinical Social Worker
CC
Melanie Doe
NIAAA
Anonymous
NIH OER
Scientist
NIH
Program Director
NIH
Jane Doe
NIH
Anonymous
Program Director
NCI
Program Official
NICHD
Program Official
NICHD
Scientist
NIH
Seriously Concerned
Program Director
NCI
Tina Doe
NIEHS
Yewi
Program Officer
NIH
Anonymous
NIH
Subject to reductions in force
Anonymous A
Former Program Analyst
NIAID
Probationary termination
Anonymous
Former Program Officer
NIA
Probationary termination
Anonymous,
Former System Administrator
NIH
Probationary termination
Anonymous
Health Specialist
NIEHS
Subject to reductions in force
Anonymous
Information Technology Specialist
NIMH
Subject to reductions in force
Anonymous
Management Analyst
NIAID
Subject to reductions in force
Anonymous
Management Analyst
NIA
Subject to reductions in force
Anonymous
NCI
Subject to reductions in force
Anonymous
NCI
Subject to reductions in force
Anonymous
NCI
Subject to reductions in force
Anonymous
NHGRI
Subject to reductions in force
Anonymous
NIA
Subject to reductions in force
Jane Doe
Management Analyst
NINDS
Subject to reductions in force
Purchasing agent
NIH
Subject to reductions in force
Anonymous
CC
Subject to reductions in force
R
Program Director
NCI
Subject to reductions in force
SEBA
NIH
Subject to reductions in force
The One Who Got Away
NIH
Subject to reductions in force
Truth matters
NCI
Subject to reductions in force
On June 9th, 2025 federal employees at the National Institutes of Health (NIH) bravely stood up for the health and safety of the American people and faithful stewardship of public resources by authoring and signing the Bethesda Declaration.
We the undersigned, stand united with these courageous and selfless public servants who are committed to their duty to the American people and the mission of the NIH, including fruitful partnership with academia.
Together, we stand up for science.
Click here to read the Open letter in support of the Bethesda Declaration.
The mission of the National Institutes of Health (NIH) is to “seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability.”
In public comments, NIH Director, Dr. Jayanta Bhattacharya, has recognized the critical nature of this mission and has described the NIH as the “crown jewel of American biomedical science”.
Unfortunately, many of the actions of the current administration are inconsistent with this mission and statement. These actions undermine the unique and productive partnership between the federal government and universities, academic medical centers, and research institutes that has served the American people well over many decades. They are damaging the hard-earned trust between the NIH, academia, and the public that is essential for long-term progress.
We commend the NIH staff who have come forward with the “Bethesda Declaration” to share concerns in the spirit of academic freedom, for the good of all. We stand with these committed professionals in support of reversing the harmful actions of this administration. We urge NIH and Department of Health and Human Services (HHS) leadership to work with NIH staff to return the NIH to its mission and to abandon the strategy of using NIH as a tool for achieving political goals unrelated to that mission.
As has been done historically, decisions and monitoring of applications and grants should be conducted by scientifically trained NIH staff through well-established processes including rigorous peer review. Such decisions must not be made by anonymous individuals outside of NIH.
Like any large organization, NIH would benefit periodic review and strategic reforms. However, any reforms should be developed in partnership with NIH staff and other stakeholders through careful and thoughtful analysis. They should not occur through arbitrary changes with no clear purpose or benefits, and without careful consideration of potential risks and adverse consequences—especially to the research participants who have entrusted NIH and its partners with their health.
The current endeavor to Make America Healthy Again (MAHA) refers to some undefined time in the past. Since 1960, the death rate due to heart disease has been cut in half, going from 560 deaths per 100,000 people to approximately 230 deaths per 100,000 today. From 1960 to the present day, the five-year survival rate for childhood leukemia has increased nearly 10-fold, to over 90% for some forms. In 1960, the rate of measles infection was approximately 250 cases per 100,000 people compared with a near zero rate now (at least until recently). These are but a few of many examples. Certainly, much work remains to better treat disease and improve the health of Americans, such as addressing increased rates of obesity, diabetes, and opioid dependency. But, glamorizing a mythical past, while ignoring important progress made through biomedical research, does not enhance the health of American people.
Before the mid-1960s, many of the advances that were ushering in a new era in biology were coming from Europe. However, with support from the NIH, the contributions of American scientists grew over the next decades and America became the internationally recognized hub for biomedical research and training. This, combined with the American entrepreneurial spirit, led to the creation of the biotechnology industry. America was an important partner in the successful international project to sequence the human genome in its entirety and to characterize many variations that contribute to health and disease susceptibility. These advances, and associated technologies, have provided profound insights into the mechanisms of many diseases, both common and rare, that are yielding opportunities for real progress to advance human health, some of which have been realized.
Now is the time to push forward the NIH mission and all that has been built to support it, not to disable it. We urge NIH and HHS leadership to work in partnership with the NIH staff members who have spoken out to refocus on this goal using time-tested processes to award and sustain support for the range of activities that drives the NIH mission, now and into the future.
Nobel Laureate Signatories
Roger Kornberg, PhD, Nobel laureate 2006 for elucidating the mechanism of DNA transcription
Carolyn Bertozzi, PhD, Nobel laureate 2022 for developing chemical tools for studying living organisms
Martin Chalfie, PhD, Nobel laureate 2008 for the development of green fluorescent protein
Joachim Frank, PhD, Nobel laureate 2017 for the development of single particle cryo-electron microscopy
Moungi Bawendi, PhD, Nobel laureate 2023 for the development of quantum dots
Victor Ambros, PhD, Nobel laureate 2024 for the discovery of microRNA
Drew Weissman, MD, PhD, Nobel laureate 2023 for discoveries concerning nucleoside base modifications that enabled the development of effective vaccines
Ardem Patapoutian, PhD, Nobel laureate 2021 for the discovery of receptors for touch
Aziz Sancar, PhD, Nobel laureate 2015 for elucidation of DNA repair mechanisms
Gregg Semenza, MD, PhD, Nobel laureate 2019 for discoveries of how cells sense and adapt to oxygen availability
Jack Szostak, PhD, Nobel laureate 2009 for discoveries about the function of telomeres and the telomerase enzyme
Carol Greider, PhD, Nobel laureate 2009 for discoveries about the function of telomeres and the telomerase enzyme
Andrew Fire, PhD, Nobel laureate 2006 for the discovery of RNA interference
Robert Horvitz, PhD, Nobel laureate 2002 for the discovery of programmed cell death
David Baker, PhD, Nobel laureate 2024 for protein structure prediction and design
W.E. Moerner, PhD, Nobel laureate 2014 for the development of super-resolution fluorescence microscopy
Rod MacKinnon, MD, Nobel laureate 2003 for discoveries concerning channels in cell membranes
Randy Schekman, PhD, Nobel laureate 2013 for discoveries regarding a major transport system in cells
William Kaelin, MD, PhD, Nobel laureate 2019 for discoveries of how cells sense and adapt to oxygen availability
Brian Kobika, MD, Nobel laureate 2012 for Studies of G-Protein coupled receptors
Thomas C. Südhof, PhD, Nobel laureate 2013 for discoveries regarding a major transport system in cells
May-Britt Moser, PhD in Neuroscience, Prof., Nobel laureate 2014 for work concerning the grid cells in the entorhinal cortex, KISN at NTNU Trondheim
Edvard Moser, Professor, Nobel laureate 2014 for work concerning the grid cells in the entorhinal cortex
Richard Roberts, PhD, Sir, Nobel laureate 1993 for the discovery of introns in eukaryotic DNA and the mechanism of gene-splicing
Jennifer Doudna, PhD, American biochemist, Nobel laureate 2020 for the development of a method for genome editing, CRISPR
Steven Chu, PhD, Prof., 1997 Nobel laureate for research regarding the cooling and trapping of atoms with laser light, Stanford University
Oliver Hart, PhD, Sir, Nobel laureate 2016 for contributions to contract theory, Harvard University
Robert Lefkowitz, MD, Nobel laureate 2012 in Chemistry for studies of G protein coupled receptors
David Politzer, PhD, Nobel laureate 2004 for discovery of asymptotic freedom in quantum chromodynamics
J Michael Bishop, MD, University Prof., Nobel laureate 1989 for discovery the first human oncogene, University of California San Francisco
Elias J. Corey, Prof., Nobel laureate 1990 for his development of the theory and methodology of organic synthesis, Harvard University
David Macmillan, PHD, Nobel laureate 2021 for the development of asymmetric organocatalysis, Princeton University
Adam Riess, Dr., Nobel laureate 2011 for providing evidence that the expansion of the universe is accelerating, Johns Hopkins University
George Smoot, Prof., Nobel laureate 2006 for discovery of the black body form and anisotropy of the cosmic microwave background radiation, Donestia International Physics Center
Paul L Modrich PhD, Nobel laureate 2015 for analysis of DNA repair mechanisms
Francoise Barre Sinoussi, PhD, Nobel laureate 2008 for discovery of HIV, Institut Pasteur
Brian Josephson, Prof. FRS, Nobel laureate 1973 for discovery of the Josephson effect, University of Cambridge
Jean-Marie Lehn, Dr., Prof., Nobel laureate 1987 for synthesis of cryptands, University of Strasboug Institute for Advanced Study (USIAS)
Michel Mayor, PhD, Prof., Nobel laureate 2019 for discovery of the first exoplanet, University of Geneva
Hartmut Michel, Dr, Prof., Nobel laureate 1988 for determination of the first crystal structure of an integral membrane protein, Max Planck Institute of Biophysics
Roger Penrose, Sir, OM, FRS, Nobel laureate 2020 for the discovery that black hole formation is a robust prediction of the general theory of relativity, University of Oxford
Brian Schmidt, Prof., Nobel laureate 2011 for providing evidence that the expansion of the universe is accelerating, Australian National University
Richard Schrock, PhD, Nobel laureate 2005 for work in the area of olefin metathesis, an organic synthesis technique, Massachusetts Institute of Technology
Robert Wilson, Dr., Nobel laureate 1978 for discovery of cosmic microwave background radiation
Johann Deisenhofer, Prof., Nobel laureate 1988 for determination of the first crystal structure of an integral membrane protein
Peter Agre, MD, Nobel laureate 2003 for discoveries concerning channels in cell membranes, Johns Hopkins Bloomberg School of Public Health
Harvey Alter, Dr., Distinguished NIH Scholar, Emeritus, Nobel laureate 2020 for the discovery of the hepatitis C virus, NIH
Cark Wieman, PhD, Prof Emeritus, Nobel laureate 2001 for producing the first true Bose–Einstein condensate, Stanford University
Susumu Tonegawa, PhD, Prof., Nobel laureate 1987 for his discovery of the genetic principle for generation of antibody diversity, MIT
Frank Wilczek, PhD, Nobel laureate 2004 for the discovery of asymptotic freedom in the theory of the strong interaction
Edmund Phelps, Nobel laureate 2006 for analysis of intertemporal trade-offs in macroeconomic policy
Paul Nurse, PhD, Sir, Nobel laureate 2001 for discoveries of protein molecules that control the division of cells in the cell cycle
Ferenc Krausz, PhD, Nobel laureate 2023 for generating and measuring the first attosecond light pulse and used it for capturing electrons’ motion inside atoms
Craig Mello, PhD, Nobel laureate 2006 for the discovery of RNA interference
John Polanyi, Nobel laureate 1986 for research in chemical kinetics.
Shelly Glashow, PhD, Nobel laureate 1979 for contributions to the theory of the unified weak and electromagnetic interaction between elementary particles
Hiroshi Amano, Nobel laureate 2014 for the invention of efficient blue light-emitting diodes which has enabled bright and energy-saving white light sources
Rai Weiss, PhD, Nobel laureate 2017 for decisive contributions to the LIGO detector and the observation of gravitational waves
Michael Rosbash, PhD, Nobel laureate 2017 for discovery of molecular mechanisms controlling the circadian rhythm, Brandeis University
Charles Rice, PhD, Dr., Prof., Nobel laureate 2020 for the discovery of Hepatitis C virus
Lou Ignarro, Nobel laureate 1998 for demonstrating the signaling properties of nitric oxide
Richard Henderson, Nobel laureate 2017 for the development of single particle cryo-electron microscopy
Anne L’Huillier, PhD, Nobel laureate 2022 for pioneering contributions to ultrafast laser science and attosecond physics
John Mather, PhD, Dr., Nobel laureate 2006 for discovery of the blackbody form and anisotropy of the cosmic microwave background radiation
Jerome I Friedman, Prof., Nobel laureate 1990 for pioneering investigations concerning deep inelastic scattering of electrons on protons and bound neutrons, which have been of essential importance for the development of the quark model in particle physics.
Kip Thorne, PhD, Nobel laureate 2017 for contributions to the LIGO detector and the observation of gravitational waves
Notable Signatories
Jeremy M. Berg, PhD, Former Director, National Institute of General Medical Sciences, NIH
Senator Angela D. Alsobrooks, Democratic Senator from Maryland
Freeman Hrabowski III, PhD, President Emeritus, University of Maryland, Baltimore County
Joshua Gordon, MD, PhD, Former Director, National Institute of Mental Health
Colette Delawalla, MA, MS, Stand Up for Science
Joanne Turner, PhD, Scientist
Carole LaBonne, PhD, President, Society for Developmental Biology
Gregg Gonsalves, PhD, Professor of Public Health and Law
Eric Dishman, Former Director, All of Us Research Program, NIH
Marie Abraham, Vice President, Institute for Patient- and Family-Centered Care
Mustafa Khokha, MD, Pediatrician
Katherine Feemster, MPH, Science & Medical Writer
Emma Mairson, MPH, Public health data scientist
Marian Jarlenski, PhD, MPH, Public health researcher
Scott W. Delaney, ScD JD, Research scientist, Harvard T.H. Chan School of Public Health
Noam Ross, Executive Director, rOpenSci
Annie Cohen, PhD, Alzheimer’s researcher and parent of neurodivergent children
Alondra Nelson, PhD, former Acting Direction, White House Office of Science and Technology Policy
Elias Theodosis, Principal Data Science at Capital One Financial Corporation
Emily York, R.N
Rebecca Groble, Myalgic encephalomyelitis advocate
Anthony Barente, Data scientist